Medicis (MRX) Reports Q3 EPS of $0.50, Beats by 8c; Guides Q4
More News related to MRX
- Medicis to Present at Piper Jaffray Annual Health Care Conference
- Piper Jaffray Upgrades Medicis Pharmaceutical (MRX) to Neutral; Gaining More Confidence
- Medicis to Present at Credit Suisse Annual Healthcare Conference
- Medicis (MRX) Reports Q3 EPS of $0.50, Beats by 8c; Guides Q4
- Medicis Reports Third Quarter 2009 Financial Results
Medicis (NYSE: MRX) reports Q3 EPS of $0.50, 8 cents better than the analyst estimate of $0.42.
Sees Q4 EPS of $0.58-$0.62, versus the consensus of $0.57.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
